新闻
11 小时之前
argenx Announces VYVGART (efgartigimod alfa) Authorized for Sale by Health Canada  for Generalized Myasthenia Gravis
临床结果上市批准免疫疗法
11 小时之前
Alvotech Provides U.S. Regulatory Update on AVT02, a High-Concentration Interchangeable Biosimilar Candidate to Humira® (adalimumab)
上市批准生物类似药申请上市加速审批
12 小时之前
Hepion Pharmaceuticals Discovers Novel Rencofilstat Action in Liver Cancer
孤儿药快速通道
2023-09-20
PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new resistant and aggressive bacterial target
合格传染病产品
2023-09-20
科学家们揭示了非酒精性脂肪肝的最新作用机制
ASH会议临床结果免疫疗法细胞疗法
2023-09-20
中国科学家发现,肝癌患者使用抗抑郁药与死亡风险降低31%有关
临床研究诊断试剂
2023-09-20
LAPIX Therapeutics Inc. Announces FDA Clearance of IND Application for its Treg-expanding Tim3/4 Agonist LPX-TI641 to Treat Multiple Sclerosis
临床申请免疫疗法临床1期
2023-09-20
Aclaris Therapeutics Announces Positive Results from Phase 1 Multiple Ascending Dose Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor
临床结果免疫疗法
2023-09-20
上市批准临床3期引进/卖出
2023-09-20
目标“改变基因编辑领域”!再生元打算这么做…
基因疗法细胞疗法